Schott to double FIOLAX tubing production in 2020

The global fight against Covid-19 has defined pharma packaging as an essential business in critical infrastructure. According to Patrick Markschlaeger executive vice-president – Business Unit Tubing, Schott AG, the current situation is very dynamic because of the increasing demand for vials and vaccines, and this will continue for at least a couple of years. Schott is building its new second tank in Jambusar. To ensure its construction as per schedule, despite the restricted supply chain, is the most significant current issue for the company. “As the export of Indian pharmaceutical products increases, the demand for high-quality products like Schott will, therefore, also increase,” he believes.   Patrick Markschlaeger executive vice-president – Business Unit Tubing, Schott AG Schott, a leading international technology group in the areas of specialty glass and glass-ceramics, has played a vital role in the development of India’s pharmaceutical industry by manufacturing high-quality pharmaceutical tubing products in Jambusar since 1998. The company offers a broad product portfolio, including ampoules, cartridges, vials, and syringes made of glass and COC polymer.   Covid-19 has caused…

Choose your subscription to read more